课题基金 / 基金详情

Mechanism for ischemic crosstoleance in central nervous system and its therapeutic application

Mechanism for ischemic crosstoleance in central nervous system and its therapeutic application
中枢神经系统缺血交叉耐受机制及其治疗应用
批准号:
17390429
负责人:
SAKABE Takefumi
金额:
$10.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

SAKABE Takefumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have previously demonstrated that repeated hyperbaric oxygen (HBO) exposure (3.5 absolute atmosphere (ATA)) prior to ischemia significantly reduced loss of hippocampal CAl neurons after transient forebrain ischemia. The present study examined 1) the effects of different pressure level of HBO, 2) neuroprotective mechanism (by using microarray technology), and 3) biological verification (by using protein synthesis inhibitor).Rats were subjected to forebrain ischemia (8 min)at 12 hours after five sessions of 100% oxygen exposure (100% 02 group) and HBO (at 2 ATA or 3.5 MA, (HBO-2ATA, -3.5ATA group, respectively)) or sham treatment (sham group). 3.5ATA-HBO maximally protected hippocampal CAl neurons (survived neurons : 68%) against ischemic damage(sham group : 2.7%, 100% 02 group : 13.5%, 2 ATA-HBO group : 44%).Microarray data showed significant up-regulation in p75^<NTR>, C/EBP δ, CD74, whose time-course expressions corresponded to HBO-induced neuroprotection. The protein levels were a … More lso significantly increased (2.9, 2.0, and 7.9, respectively). Further, we examined the modulation of neuroprotection by administering protein synthesis inhibitor, anisomycin (AM) or cycloheximide (CY) prior to HBO exposure, both of which inhibited HBO-induced neuroprotection, survived neuron being 2.1 and 8.9% in the rats treated with AM and CY, respectively. With administration of p38 MAP kinase inhibitor, SB203580 (SB), before each treatment with AM-HBO, HBO-induced neuroprotection was resumed. In contrast, with administration of SB before each treatment with CY-HBO, HBO-induced neuroprotection was only marginal. Because AM, but not CY, has been known to have activating property of p38 mitogen-activated protein (p38MAP) kinase, our results suggest that the mechanism of HBO-induced neuroprotection is involved in suppression of p38 MAP kinase.In conclusion, HBO induced neuroprotection against the neuronal damage in the hippocampal CAl following forebrain ischemia is mediated by de novo protein synthesis relevant to neurotrophin and inflammatory-immune system and to suppression of p38 MAP kinase. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.brainres.2006.10.077
发表时间: 2007-01-26
期刊: BRAIN RESEARCH
影响因子: 2.9
作者: [Hirata, Takao, Cui, Ying Jun, Sakabe, Takefumi]
通讯作者: Sakabe, Takefumi
Ischemic tolerance induced by repeated hyperbaric oxygen In rat brain:Time window and genome-wide gene and protein expression
重复高压氧诱导大鼠脑缺血耐受:时间窗和全基因组基因和蛋白表达
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Takao Hirata, et. al.]
通讯作者: et. al.
中枢神経における虚血耐性
中枢神经系统的缺血耐受性
DOI: --
发表时间: 2005
期刊: 蘇生 24
影响因子: --
作者: [松本 美志也, 他, Takao Hirata, 山下 敦, 松本 美志也]
通讯作者: 松本 美志也
Ischemic preconditioning in the central nervous system
中枢神经系统缺血预处理
DOI: --
发表时间: 2005
期刊: Japanese Journal of Reanimatology 24
影响因子: --
作者: [Mishiya, Matsumoto, Kazuhiko, Nakakimura, Mitsuyoshi, Yoshida, Takao, Hirata, Takefumi, Sakabe]
通讯作者: Sakabe
11
    Investigation on therapeutic potentials of inducing ischemic tolerance against ischemic neuronal damage in the spinal cord
    • 批准号:
      14370490
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2002
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    The machanism of delayed motor neuron death after transient spinal cord ischemia
    • 批准号:
      11470323
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    The pathogenesis and treatment of cerebral ischemia based on the mechanism of cytoskeletal changes
    • 批准号:
      07457357
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.26万
    • 财政年份:
      1995
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    Experimental studies of pathophysiology and treatment of spinal cord ischemia
    • 批准号:
      05454423
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.67万
    • 财政年份:
      1993
    • 负责人:
      SAKABE Takefumi
    • 依托单位:
    海外基金